The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Paul Abrams

Bristol Urological Institute

Southmead Hospital

Bristol

BS10 5NB

UK

[email]@bui.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Bristol Urological Institute, Southmead Hospital, Bristol, BS10 5NB, UK. 2001 - 2011
  • Bristol Urological Institute, Bristol, UK. 2010
  • Southmead Hospital, Bristol, UK. 2000

References

  1. Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome. Abrams, P., Chapple, C.R., Jünemann, K.P., Sharpe, S. World. J. Urol (2011) [Pubmed]
  2. International Consultation on Urological Diseases: Evidence-based medicine overview of the main steps for developing and grading guideline recommendations. Abrams, P., Khoury, S. Neurourol. Urodyn. (2010) [Pubmed]
  3. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Abrams, P., Andersson, K.E., Buccafusco, J.J., Chapple, C., de Groat, W.C., Fryer, A.D., Kay, G., Laties, A., Nathanson, N.M., Pasricha, P.J., Wein, A.J. Br. J. Pharmacol. (2006) [Pubmed]
  4. Assessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measures. Abrams, P., Artibani, W., Gajewski, J.B., Hussain, I. Urology (2006) [Pubmed]
  5. Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Abrams, P., Swift, S. Eur. Urol. (2005) [Pubmed]
  6. A proposal for a new classification for operative procedures for stress urinary incontinence. Abrams, P., Hilton, P., Lucas, M., Smith, T. BJU Int. (2005) [Pubmed]
  7. Urgency: the key to defining the overactive bladder. Abrams, P. BJU Int. (2005) [Pubmed]
  8. NICE urology: coming to a country near you?. Abrams, P., Campbell, B. BJU Int. (2005) [Pubmed]
  9. The role of neuromodulation in the management of urinary urge incontinence. Abrams, P., Blaivas, J.G., Fowler, C.J., Fourcroy, J.L., Macdiarmid, S.A., Siegel, S.W., Van Kerrebroeck, P. BJU Int. (2003) [Pubmed]
  10. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. Abrams, P., Amarenco, G., Bakke, A., Buczyński, A., Castro-Diaz, D., Harrison, S., Kramer, G., Marsik, R., Prajsner, A., Stöhrer, M., Van Kerrebroeck, P., Wyndaele, J.J. J. Urol. (2003) [Pubmed]
  11. Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine. Abrams, P., Malone-Lee, J., Jacquetin, B., Wyndaele, J.J., Tammela, T., Jonas, U., Wein, A. Drugs. Aging (2001) [Pubmed]
  12. Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder. Abrams, P. Expert. Opin. Pharmacother (2001) [Pubmed]
  13. Facts and future lines of research in prostate cancer: concluding remarks. Abrams, P. BJU Int. (2000) [Pubmed]
 
WikiGenes - Universities